Copanlisib (BAY 80-6946)
99%
- Product Code: 100158
CAS:
1032568-63-0
| Molecular Weight: | 480.52 g./mol | Molecular Formula: | C₂₃H₂₈N₈O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD18633201 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Copanlisib is primarily used in the treatment of certain types of cancer, particularly relapsed follicular lymphoma. It works by inhibiting specific enzymes in the body that are involved in the growth and survival of cancer cells. This targeted approach helps to slow down or stop the progression of the disease. It is often administered intravenously in a clinical setting, allowing for controlled dosing and monitoring. The use of Copanlisib is typically considered when other treatments have not been effective, providing an alternative option for patients with limited choices. Its application is closely monitored by healthcare professionals to manage potential side effects and ensure the best possible outcomes for patients.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Pale Yellow Powder |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿3,370.00 |
+
-
|
| 0.005 | 10-20 days | ฿11,600.00 |
+
-
|
Copanlisib (BAY 80-6946)
Copanlisib is primarily used in the treatment of certain types of cancer, particularly relapsed follicular lymphoma. It works by inhibiting specific enzymes in the body that are involved in the growth and survival of cancer cells. This targeted approach helps to slow down or stop the progression of the disease. It is often administered intravenously in a clinical setting, allowing for controlled dosing and monitoring. The use of Copanlisib is typically considered when other treatments have not been effective, providing an alternative option for patients with limited choices. Its application is closely monitored by healthcare professionals to manage potential side effects and ensure the best possible outcomes for patients.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :